Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE: 300026)

Tianjin Chase Sun Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,649	1,574	1,206	1,316	1,126	987.97
Cash & Short-Term Investments	1,649	1,574	1,206	1,316	1,126	987.97
Cash Growth	41.87%	30.46%	-8.34%	16.89%	13.95%	-18.25%
Accounts Receivable	3,076	2,892	3,546	3,694	2,852	2,170
Other Receivables	40.56	50.09	49.94	59.23	44.68	59.34
Receivables	3,117	2,942	3,596	3,753	2,897	2,230
Inventory	1,894	1,961	2,214	1,305	1,417	892.16
Prepaid Expenses	19.67	13.25	32.11	16.77	-	47.62
Other Current Assets	218.57	230.06	336.93	416.22	274.33	168.86
Total Current Assets	6,897	6,720	7,385	6,806	5,714	4,326
Property, Plant & Equipment	3,220	3,242	3,322	2,901	2,556	2,306
Long-Term Investments	246.38	247.62	244.03	272.82	274	297.74
Goodwill	692.54	692.54	716.05	716.05	799.18	799.18
Other Intangible Assets	313.03	331.11	352.73	313.68	232.4	236.78
Long-Term Accounts Receivable	46.37	46.37	94.1	115.01	101.49	-
Long-Term Deferred Tax Assets	185.05	129.29	140.56	108.16	114.48	85.35
Long-Term Deferred Charges	404.02	402.6	327.29	311.53	343.42	297.87
Other Long-Term Assets	19.87	23.14	77.68	62.51	44.47	77.06
Total Assets	12,025	11,835	12,660	11,607	10,180	8,427
Accounts Payable	704.2	713.45	884.77	605	535.7	492.38
Accrued Expenses	311.38	184.08	444.37	519.36	321.06	182.7
Short-Term Debt	10.91	23.18	231.47	293.79	792.84	324.81
Current Portion of Long-Term Debt	199.75	167.67	380.77	100.02	4.55	-
Current Portion of Leases	40.19	25.88	55.07	45.86	-	-
Current Income Taxes Payable	23.3	20.61	9.82	15.12	33.04	2.97
Current Unearned Revenue	58.57	76.27	208.03	137.56	132.08	52.62
Other Current Liabilities	332.94	353.7	463.6	341.56	520.74	177.15
Total Current Liabilities	1,681	1,565	2,678	2,058	2,340	1,233
Long-Term Debt	1,204	1,257	1,345	1,458	362.03	45
Long-Term Leases	110.09	59.42	78.12	67.07	-	-
Long-Term Unearned Revenue	60.57	62.56	62.04	67.55	74.06	54.13
Long-Term Deferred Tax Liabilities	37.91	23.2	33.81	3.95	4.22	4.49
Other Long-Term Liabilities	-	-	-	-	7.44	20
Total Liabilities	3,093	2,967	4,197	3,655	2,788	1,356
Common Stock	3,004	3,004	3,004	3,004	3,004	3,006
Additional Paid-In Capital	589.49	589.49	589.49	589.49	584.28	586.15
Retained Earnings	5,170	5,112	4,695	4,199	3,642	3,215
Comprensive Income & Other	5.58	4.75	0.86	-19.98	-36.43	-20.9
Total Common Equity	8,769	8,710	8,290	7,773	7,194	6,786
Minority Interest	162.08	157.7	172.87	179.49	197.75	283.92
Shareholders' Equity	8,931	8,868	8,463	7,952	7,392	7,070
Total Liabilities & Equity	12,025	11,835	12,660	11,607	10,180	8,427
Total Debt	1,565	1,533	2,091	1,965	1,159	369.81
Net Cash (Debt)	83.94	40.24	-884.45	-648.87	-33.64	618.16
Net Cash Growth	-	-	-	-	-	-37.72%
Net Cash Per Share	0.03	0.01	-0.30	-0.22	-0.01	0.21
Filing Date Shares Outstanding	3,004	3,004	3,004	3,004	3,004	3,006
Total Common Shares Outstanding	3,004	3,004	3,004	3,004	3,004	3,006
Working Capital	5,216	5,155	4,707	4,748	3,374	3,094
Book Value Per Share	2.92	2.90	2.76	2.59	2.39	2.26
Tangible Book Value	7,763	7,686	7,221	6,743	6,163	5,750
Tangible Book Value Per Share	2.58	2.56	2.40	2.24	2.05	1.91
Buildings	1,985	1,988	1,730	1,651	1,605	1,259
Machinery	2,539	2,514	2,155	1,852	1,665	1,384
Construction In Progress	73.68	54.11	461.01	232.93	64.18	311.37

Source: S&P Capital IQ. Standard template. Financial Sources.